Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotaverine and ibuprofen alone versus in combination for dysmenorrhea
2004-003809-25Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of drotaverine, ibuprofen in dysmenorrhea, primary dysmenorrhea (PD), Secondary dysmenorrhea, sponsored by Sanofi. Started Oct 2004; status: terminated.
02
Drugs
drotaverineibuprofen
03
Conditions
dysmenorrheaprimary dysmenorrhea (PD)Secondary dysmenorrhea
Beyond the preview
Go deeper on 2004-003809-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003809-25.